4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001415889-25-023700
PRESIDENT AND CEO acquired 195,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bashan Dror PRESIDENT AND CEO | 2025-09-03 | Grant or award | +195,000 | 2,344,418 | I | ||
| Derivatives | |||||||
| Bashan Dror PRESIDENT AND CEO | 2025-09-03 | Grant or award · Stock Option (Right to Buy) | +340,000 | 340,000 | D | ||
Loading xslF345X05/form4-09042025_050901.xml…